Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy and safety of a bodyweight-adjusted higher dose of ocrelizumab in relapsing (MUSETTE) and primary progressive (GAVOTTE) multiple sclerosis: two multicentre, randomised, double-blind, parallel-group phase 3b trials.
Journal: Lancet (London, England)
Published: October 30, 2025
Validated, Quantitative, Machine Learning-Generated Neurologic Assessment of Multiple Sclerosis Using a Mobile Application.
Journal: International journal of MS care
Published: March 14, 2024
Insights for Healthcare Providers on Shared Decision-Making in Multiple Sclerosis: A Narrative Review.
Journal: Neurology and therapy
Published: September 06, 2023
Practical Considerations for Managing Pregnancy in Patients With Multiple Sclerosis: Dispelling the Myths.
Journal: Neurology. Clinical practice
Published: June 30, 2023
Interim guidelines for the assessment and treatment of pain in children with multiple sclerosis.
Journal: Frontiers in neuroscience
Published: June 07, 2023
A retrospective evaluation of seroconversion after COVID-19 during the early Omicron wave in fully vaccinated multiple sclerosis patients receiving anti-CD20 therapies.
Journal: Multiple sclerosis and related disorders
Published: September 02, 2022
Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications.
Journal: Multiple sclerosis and related disorders
Published: September 20, 2021
Validation of claims-based diagnoses of adult and pediatric neuromyelitis optica spectrum disorder and variations in diagnostic evaluation and treatment initiation.
Journal: Multiple sclerosis and related disorders
Published: September 23, 2019
Severe acute inflammatory demyelinating polyradiculoneuropathy with persistent weakness associated with tumor-like nerve root enlargement.
Journal: Journal of clinical neuromuscular disease
Published: May 22, 2015
Use of therapies other than disease-modifying agents, including complementary and alternative medicine, by patients with multiple sclerosis: a survey study.
Journal: The Journal of the American Osteopathic Association
Published: February 04, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026